이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Effective Communication in Perinatal Care (ComPARE)

2026년 11월 2일 업데이트: Candiani Massimo, IRCCS San Raffaele

ComPARE: Effective COMmunication in Perinatal cARE Cross-sectional Study

ComPARE is a cross-sectional observational study investigating the effectiveness of communication during prenatal consultations concerning vaginal birth after caesarean (VBAC). It involves 50 pregnant people considering VBAC and 12 healthcare professionals from IRCCS Ospedale San Raffaele: 6 OB-GYNs and 6 midwives with expertise in VBAC. The main objective is to identify and analyse misunderstandings in doctor/midwife-patient communication, using the TouCAN Codebook, and to examine whether these misunderstandings are associated with patients' perceptions of communication quality. The study does not introduce any treatment or medical device: it analyses routine clinical consultations. The study period is 5 years, with 2 years of enrolment.

연구 개요

상태

모병

정황

상세 설명

ComPARE (effective COMmunication in Perinatal cARE) is a cross-sectional observational study investigating the clarity, accessibility, and effectiveness of communication between healthcare professionals and pregnant individuals during prenatal consultations concerning vaginal birth after caesarean (VBAC).

Doctor-patient communication is an integral component of clinical care and is essential for establishing trust, supporting patient autonomy and shared decision-making, and promoting patient safety and quality of care. In clinical communication, misunderstandings may arise not only from the explicit content of what is said, but also from implicit assumptions, contextual cues, presuppositions, and non-literal meanings. The TouCAN Codebook (Textual misUnderstanding Codebook ANalysis) provides a structured linguistic framework for identifying markers of potentially problematic communication that may hinder mutual understanding. The present study applies this approach to perinatal care, with a specific focus on consultations concerning VBAC.

The study addresses the need for research specifically examining communication practices in VBAC counselling. These consultations involve the communication of complex and risk-sensitive information concerning pregnancy and birth and require information to be conveyed in a clear and accessible manner to support informed and autonomous decision-making.

The study population consists of 50 pregnant individuals considering VBAC and 12 healthcare professionals from IRCCS Ospedale San Raffaele, including 6 obstetricians and gynaecologists (OB-GYNs) and 6 midwives with expertise in VBAC. Eligible pregnant participants are Italian-speaking individuals aged 18-44 years with a singleton pregnancy between 33 and 37 weeks of gestation, a history of caesarean section in a previous pregnancy, and a scheduled VBAC counselling consultation at IRCCS Ospedale San Raffaele. Participants must provide written informed consent and plan to deliver at San Raffaele Hospital.

The study is non-interventional and does not involve medicinal products, medical devices, diagnostic procedures, or therapeutic interventions outside routine clinical practice. The clinical consultation is conducted according to standard care, and participation in the study does not influence the healthcare professional's clinical decisions or the diagnostic or therapeutic pathway.

The study procedures include three main components. First, the participant attends the scheduled outpatient prenatal consultation with an OB-GYN or midwife experienced in VBAC. The consultation is audio-recorded to allow subsequent linguistic analysis. Second, following the consultation, the participant takes part in the SSI-CLAR semi-structured interview, lasting approximately 30 minutes, which assesses the participant's perceived clarity of communication, tone, accessibility of language, and subjective understanding of the information received. The interview is also audio-recorded and subsequently analysed using thematic analysis. Third, after delivery, information is collected concerning the method of delivery, specifically whether the participant underwent VBAC or caesarean section and, in the case of caesarean section, the clinical indication.

The primary objective is to evaluate the clarity and effectiveness of communication between healthcare professionals (OB-GYNs and midwives) and pregnant individuals during prenatal consultations concerning VBAC. The primary endpoint is the level of misunderstanding in clinician-patient conversations, measured through systematic analysis of consultation transcripts using the TouCAN Codebook. Coded misunderstandings will be quantified as counts and, where appropriate, as rates per consultation. Inter-rater reliability will also be assessed.

A secondary objective is to assess whether there is a match or mismatch between patterns of misunderstanding identified in clinical conversations and patients' own perceptions of communication as reported in the post-consultation interviews. The secondary endpoint is the degree of convergence or divergence between the level and types of misunderstandings identified through TouCAN Codebook coding and patients' perceived clarity and understanding as assessed through the semi-structured interviews.

The study will also explore the association between communication characteristics, perceived clarity, and the participant's subsequent decision regarding VBAC or a new caesarean section. Quantitative analyses will include descriptive statistics and exploratory Spearman correlations. A linear mixed-effects model will be used to explore the relationship between communication characteristics and perceived clarity, accounting for clustering at the clinician level. A logistic regression model will explore the association between communication characteristics and delivery outcomes. These quantitative analyses are exploratory and hypothesis-generating and are not intended to establish causal or predictive relationships.

The qualitative analysis of consultation transcripts will focus on identifying and characterising linguistic markers of misunderstanding using the TouCAN Codebook. Interview data will be analysed through thematic analysis, following a six-phase approach involving independent coding and collaborative synthesis. The combination of linguistic analysis and participants' subjective accounts is intended to capture both observable features of communication and patients' own perceptions of clarity, understanding, and communication quality.

All study data are collected in connection with the routine prenatal consultation and the subsequent assessment of communication and understanding. Participant involvement lasts approximately two hours. No additional clinical risk or therapeutic intervention is introduced by the study.

The study has a total duration of five years, with participant enrolment lasting two years. The study is sponsored by IRCCS Ospedale San Raffaele and co-sponsored by Università Vita-Salute San Raffaele. The Principal Investigator is Prof. Massimo Candiani.

연구 유형

관찰

등록 (추정된)

50

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

샘플링 방법

비확률 샘플

연구 인구

The study population will consist of approximately 50 pregnant participants with a history of previous caesarean delivery who are considering vaginal birth after caesarean (VBAC). Participants will be recruited among patients attending prenatal counselling consultations at IRCCS Ospedale San Raffaele, Milan, Italy. Eligible participants will be between 18 and 44 years of age, have a singleton pregnancy between 33 and 37 weeks of gestation, and be planning delivery at the study hospital. The study will examine communicative misunderstandings during prenatal counselling and patients' perceptions of the information exchanged.

설명

Inclusion Criteria

  1. Singleton pregnancy.
  2. Gestational age between 33 and 37 weeks at the time of the prenatal consultation.
  3. Maternal age between 18 and 44 years, inclusive.
  4. Ability to communicate in Italian and understand the study procedures.
  5. History of at least one previous caesarean delivery.
  6. Planned delivery at IRCCS Ospedale San Raffaele.
  7. Provision of written informed consent for study participation and audio recording of the consultation.

Exclusion Criteria

  1. Multiple pregnancy.
  2. Obstetric emergencies or urgent clinical conditions requiring immediate medical intervention that would prevent the planned prenatal counselling consultation.
  3. Inability to provide valid informed consent.
  4. Refusal of audio recording of the consultation.
  5. Clinical or logistical circumstances preventing participation in the interview following the consultation.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: CROSS_SECTIONAL

코호트 및 개입

그룹/코호트
Pregnant people considering VBAC

Pregnant individuals aged 18 to 44 years with a singleton pregnancy between 33 and 37 weeks of gestation, a history of caesarean section in a previous pregnancy, and a scheduled VBAC counselling consultation at IRCCS Ospedale San Raffaele. Participants must be Italian speakers, provide written informed consent, and plan to deliver at San Raffaele Hospital. The study is observational and involves no experimental intervention. Participants undergo their scheduled routine VBAC consultation, which is audio recorded for linguistic analysis, followed by a semi structured interview assessing their perceived understanding and clarity of the information received. Information on the subsequent mode of delivery is also collected after delivery. A total of 50 pregnant participants are planned.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Level of misunderstanding in clinician-patient conversations
기간: During the prenatal consultation (Day 1)

he primary endpoint is the level of misunderstanding in clinician-patient conversations, measured through systematic analysis of consultation transcripts using the TouCAN Codebook.

During the prenatal consultation (Day 1)

2차 결과 측정

결과 측정
측정값 설명
기간
Convergence or divergence between consultation based misunderstanding and patients' perceived communication
기간: On the day of the prenatal consultation (Day 1)

The degree of convergence or divergence between (a) the level and types of misunderstandings identified through TouCAN Codebook coding of consultations and (b) patients' perceived clarity and understanding as assessed via semi structured interviews.

On the day of the prenatal consultation (Day 1)

기타 결과 측정

결과 측정
측정값 설명
기간
Descriptive mapping of the types of communicative misunderstandings observed across consultations
기간: During the prenatal consultation (Day 1)

Descriptive mapping of the types of communicative misunderstandings observed across consultations.

During the prenatal consultation (Day 1)
Convergence or divergence between misunderstandings, perceived clarity and delivery decision
기간: During the prenatal consultation (Day 1)

The degree of convergence or divergence between (a) the level and types of misunderstandings identified through TouCAN Codebook coding of consultations, (b) patients' perceived clarity and understanding as assessed via semi structured interviews and (c) the decision of the pregnant person to undergo a VBAC or a CS.

During the prenatal consultation (Day 1)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 9월 16일

기본 완료 (추정된)

2029년 9월 16일

연구 완료 (추정된)

2031년 9월 16일

연구 등록 날짜

최초 제출

2026년 9월 16일

QC 기준을 충족하는 최초 제출

2026년 11월 2일

처음 게시됨 (실제)

2026년 11월 5일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 2일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • ComPARE - CET 209-2026

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .